Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm, single center, phase II study

Romain Schollhammer, Grégoire Robert, Julien Asselineau, Mokrane Yacoub, Delphine Vimont, Nicolas Balamoutoff, Franck Bladou, Antoine Bénard, Elif Hindié, Henri H de Clermont-Gallerande, Clément Morgat
J Nucl Med. 2022-09-02; : jnumed.122.263889
DOI: 10.2967/jnumed.122.263889


Lire sur PubMed

---

Schollhammer R(1), Robert G(2), Asselineau J(3), Yacoub M(4), Vimont D(5), Balamoutoff N(1), Bladou F(2), Bénard A(3), Hindié E(1), de Clermont-Gallerande HH(1), Morgat C(1).

Author information:
(1)Nuclear Medicine Department, Bordeaux University Hospital, France.
(2)Department of Urology, Bordeaux University Hospital, France.
(3)CHU Bordeaux, Public Health Department, Clinical Epidemiology Unit, France.
(4)Department of Pathology, Bordeaux University Hospital, France.
(5)INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, France.

Auteurs Bordeaux Neurocampus